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Justin J. Rochford 3,*ABSTRACT
Objective: Disruption of the genes encoding either seipin or 1-acylglycerol-3-phosphate O-acyltransferase 2 (AGPAT2) causes severe congenital
generalized lipodystrophy (CGL) in humans. However, the function of seipin in adipogenesis remains poorly deﬁned. We demonstrated recently
that seipin can bind the key adipogenic phosphatidic acid (PA) phosphatase lipin 1 and that seipin forms stable dodecamers. As AGPAT2
generates PA, the substrate for lipin 1, we investigated whether seipin might bind both enzymes of this lipid biosynthetic pathway, which is
required for adipogenesis to occur.
Methods: We employed co-immunoprecipitation and immunoﬂuorescence methods to determine whether seipin can interact with AGPAT2 and
the consequences of this in developing adipocytes. Atomic force microscopy was used to determine whether these interactions involved direct
association of the proteins and to deﬁne the molecular architecture of these complexes.
Results: Our data reveal that seipin can bind AGPAT2 during adipogenesis and that stabilizing this interaction during adipogenesis can increase
the nuclear accumulation of PPARg. Both AGPAT2 and lipin 1 can directly associate with seipin dodecamers, and a single seipin complex can
simultaneously bind both AGPAT2 and lipin with a deﬁned orientation.
Conclusions: Our study provides the ﬁrst direct molecular link between seipin and AGPAT2, two proteins whose disruption causes CGL.
Moreover, it provides the ﬁrst example of an interaction between seipin and another protein that causally inﬂuences a key aspect of adipogenesis.
Together our data suggest that the critical role of seipin in adipogenesis may involve its capacity to juxtapose important regulators of this process
in a multi-protein complex.
 2015 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Homozygous disruption of either BSCL2 or AGPAT2, encoding seipin
and 1-acylglycerol-3-phosphate O-acyltransferase 2 (AGPAT2)
respectively, causes a very severe congenital generalized lipodys-
trophy (CGL). Affected individuals display a striking lack of adipose
tissue and suffer severe metabolic disease [1e4]. Both seipin and
AGPAT2 have critical cell-autonomous roles in adipogenesis, and the
loss of these functions is likely to explain the failure of patients to
develop adipose tissue [5e9].
AGPAT2 converts lysophosphatidic acid (LPA) to phosphatidic acid
(PA), a key step in the synthesis of both phospholipids and tri-
acylglycerol (TG). Loss of AGPAT2 in preadipocytes causes a failure to
induce adipogenic gene expression before TG accumulation would
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the accumulation of inhibitory lipid signals, and not impaired TG
synthesis per se, is the primary cause of failed adipogenesis in AGPAT2
deﬁciency [9].
Despite its critical role in human adipose tissue development, the
molecular role of seipin in adipogenesis remains uncertain. Several
studies have suggested an evolutionarily conserved role for seipin in
lipid droplet biogenesis [10e18]. Seipin-deﬁcient mouse embryonic
ﬁbroblasts (MEFs) display increased lipolysis and consequent loss of
lipid accumulation [19,20]; however, the molecular basis of this
observation remains uncertain. Seipin has also been shown to bind the
adaptor protein 14-3-3b in developing adipocytes and may inﬂuence
adipogenesis via cytoskeletal remodelling [21]. However, the speciﬁc
loss of 14-3-3b during adipogenesis causes reduced lipid accumu-
lation, but not the failure of adipogenic gene expression observed withersity of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science,
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Original articleseipin disruption. A recent study has also demonstrated that seipin can
bind the sarco/endoplasmic reticulum Ca2þ-ATPase, SERCA, and may
modulate its activity [22]. However, it is not clear how or if this may
inﬂuence adipogenesis.
We demonstrated previously that seipin can bind the key adipogenic
PA phosphatase lipin 1 [23]. The loss of seipin in developing adi-
pocytes reduces the quantity of lipin bound to the endoplasmic re-
ticulum (ER), where seipin resides, and increases the levels of PA
[23]. The effects of lipin or seipin loss on the induction of genes
regulating adipogenesis are remarkably similar, and so the binding of
lipin at the ER may represent a critical role for seipin in adipocyte
development.
We also showed recently, that human seipin forms homo-oligomers of
twelve subunits [24], similar to the nine-subunit homo-oligomers re-
ported for its orthologue in yeast [25]. This led us to speculate that seipin
dodecamers might provide a docking nexus around which several
molecules could be arranged. AGPAT2 lies immediately upstream of lipin
1 in the same lipid biosynthetic pathway, and loss of either enzyme or
seipin inhibits adipogenesis in a similar manner. Hence, we investigated
whether seipin might act to juxtapose AGPAT2 and lipin 1.
2. MATERIALS AND METHODS
2.1. Cell culture
HEK293 cells were cultured in DMEM containing 10% FBS and
transiently transfected using Fugene 6 transfection reagent (Promega)
as in [24]. 3T3-L1 preadipocytes were cultured and differentiated as
previously described [23]. Differentiating adipocytes were transiently
transfected as in [23] using Lipofectamine LTX (Invitrogen). For BiFC
experiments, HEK293 or 3T3-L1 cells were grown on glass cover-
slips, transfected with S-Yn, Yn-S, A-Yc and Yc-A plasmids using
Fugene 6 (Roche) or Lipofectamine LTX, respectively. HEK293 cells
were incubated at 37 C for 4 h, at 32 C for 20 h then at 30 C for
2 h. Cells were then ﬁxed or harvested, permeabilized, blocked and
probed as previously described [23]. For AFM experiments, tsA 201
cells (a subclone of HEK293) were grown in DMEM containing 10%
FBS and transiently transfected using calcium phosphate precipita-
tion. A total of 250 mg of DNA was used to transfect cells in
5  162 cm2 culture ﬂasks, and cells were harvested 48 h later in a
total volume of 9 ml. Approximately 8 ml of a Triton X-100 extract of
the cells was incubated with 50 ml of appropriate immunoresin in
order to immunoprecipitate proteins for AFM analysis.
2.2. Constructs
Constructs to express FLAG-seipin, FLAG-AGPAT2 and FLAG-seipin-
Myc were generated in the pCMV3xFLAG vector (SigmaeAldrich).
Seipin-Myc and AGPAT2-Myc were in the pcDNA3.1/Myc-His vector
(LifeTechnologies), and HA-lipin 1 was cloned in pCMV (Sigmae
Aldrich) as previously described [7,8,23,24]. Fusion constructs for BiFC
experiments were generated essentially as in [23]. Brieﬂy, the N-ter-
minal (1e158) fragment of YFP was inserted downstream or upstream
of seipin in pCMV3xFLAG to generate S-Yn and Yn-S fusion constructs,
respectively. The C-terminal (155e239) fragment was ampliﬁed and
inserted downstream or upstream of Myc-tagged AGPAT2 in pcDNA3.1/
Myc-His to make A-Yc and Yc-A fusion constructs, respectively.
2.3. Immunoprecipitations and immunoblotting
Lysates and anti-FLAG or anti-Myc immunoprecipitates were prepared
as described in [23,24]. Brieﬂy, 48 h after transfection HEK293 cells were
lysed in n-octyl-b-D-glucopyranoside (ODG) lysis buffer comprising
50 mM ODG, 50 mM Tris, pH 6.8, 150 mM NaCl, 1 mM EDTA200 MOLECULAR METABOLISM 4 (2015) 199e209  2015 The Authors. Published by Elseviersupplemented with protease inhibitors (Complete EDTA-free, Roche
Applied Science) and phosphatase inhibitor cocktails (SigmaeAldrich).
All subsequent steps were performed on ice. Cells were sonicated at
medium intensity for two cycles of 30 s, incubated on ice for 20 min,
centrifuged at 16,000 g for 10 min at 4 C and supernatants retained.
Lysate containing 1 mg of protein was added to 30 ml of anti-FLAG-
agarose beads (SigmaeAldrich) pre-equilibrated with ODG lysis buffer
and ODG lysis buffer added to a ﬁnal volume of 800 ml. Tubes were
rotated gently for 2 h at 4 C. Following centrifugation (8,200 g for 30 s at
4 C) supernatants were removed and beads washed three times with
ODG lysis buffer. Excess lysis buffer was removed after the ﬁnal wash.
FLAG-tagged proteins were eluted from beads by addition of 100 ml of
200 ng/ml 3xFLAG peptide (SigmaeAldrich) in TBS (50 mM TriseHCl, pH
7.4, 150 mM NaCl) and incubated with gentle rotation for 30 min at 4 C.
Beads were then centrifuged and supernatant transferred to a new tube.
Lithium dodecyl sulfate (LDS) sample buffer (Invitrogen) was added to
20 mg of lysate and 20 ml of IP samples. Lysate and IP samples to be
probed for seipin were not heated prior to loading to prevent aggre-
gation. All other samples were heated to 95 C for 5 min. Samples
were separated by SDS-PAGE and transferred onto nitrocellulose
membranes. Immunoblots were probed with antibodies to Myc (clone
4A6 Millipore), FLAG (SigmaeAldrich), HA (Covance HA.11 clone
16B12), lipin 1 (generously provided by Symeon Siniossoglou, CIMR,
Cambridge, UK) or calnexin (Abcam), followed by horseradish peroxi-
dase (HRP)-linked secondary antibodies (Cell Signaling & Thermo
Scientiﬁc). Proteins were visualized by ECL (GE Healthcare) and imaged
using the Bio-Rad ChemiDoc system.
2.4. BiFC and immunoﬂuorescence
Antibodies used were as described for immunoblotting. Highly cross-
adsorbed Alexa Fluor anti-mouse 594, anti-rabbit 594 or anti-mouse
488 secondary antibodies were used for detection (Invitrogen). Im-
ages were acquired and BiFC quantiﬁcation was as described in
[23].
2.5. AFM imaging of isolated proteins
Transfected tsA 201 cells were lysed and proteins isolated and eluted
from anti-Myc, anti-HA or anti-FLAG agarose as described in [26].
Isolated proteins were imaged using ‘tapping’ mode in air, as
described previously [24]. Particle heights and diameters were
measured manually by the Nanoscope software and used to calculate
the molecular volume of each particle using the equation
Vm ¼ ðph=6Þ

3r 2 þ h2 (1)
where h is the particle height and r is the radius [27]. This equation
assumes that the adsorbed particles adopt the form of a spherical cap.
Molecular volume based on molecular mass was calculated using the
equation
Vc ¼ ðM0=N0ÞðV1 þ dV2Þ (2)
where M0 is the molecular mass, N0 is Avogadro’s number, V1 and V2
are the partial speciﬁc volumes of particle (0.74 cm3/g) and water
(1 cm3/g), respectively, and d is the extent of protein hydration (taken
as 0.4 g water/g protein).
2.6. Statistical analysis
Quantitative data are represented as mean  SEM. For statistical
analysis the differences between groups were examined with ANOVA
followed by a Tukey’s post-hoc test. P < 0.05 was considered sta-
tistically signiﬁcant.GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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3. RESULTS
3.1. Seipin can associate with AGPAT2
In co-immunoprecipitation experiments, Myc-tagged human AGPAT2
could be detected in anti-FLAG immunoprecipitates of HEK293 cells
where AGPAT-Myc was co-expressed with FLAG-tagged seipin
(Figure 1A). The interaction was observed with both the short 398-
amino acid translation of seipin and the long form of the protein
containing an additional 64 amino acids at the N terminus. To deﬁne
the regions of seipin important for this interaction, we used mutant
forms of seipin lacking either the cytosolic N terminus (DNT), ﬁrst
transmembrane domain (DTM1), ER luminal loop (Dloop), second
transmembrane domain (DTM2) or cytosolic C terminus (DCT).
Deletion of the ER luminal loop of seipin signiﬁcantly impaired its
interaction with AGPAT2, whilst almost no AGPAT2 could be immu-
noprecipitated with the DTM1 form of seipin (Figure 1B,C). Although
the DTM1 mutant of seipin may have altered topology, previous
studies have shown that this mutant is mostly membrane associatedFigure 1: Seipin can associate with AGPAT2 in intact cells. (A) HEK293 cells were transfe
translation of FLAG-seipin. Lysates and anti-FLAG immunoprecipitated proteins were separ
probed for calnexin as a loading control. (B) HEK293 cells were transfected with FLAG-AGP
the N terminus (DNT), ﬁrst transmembrane domain (DTM1), ER luminal loop region (DLP),
immunoprecipitates were immunoblotted for FLAG, Myc and calnexin. (C) Quantiﬁcation of
Data are means  SEM (n ¼ 3). ** indicates p < 0.01, *** indicates p < 0.001 versus co
constructs in which the N-terminal fragment of YFP was fused to the N terminus (Yn-S) or
was fused to either the N terminus (Yc-A) or the C terminus (A-Yc) of AGPAT2-Myc. Followi
stained for AGPAT2-Myc (red) and DAPI to label nuclei. The direct interaction between seipi
(E) Quantiﬁed BiFC signal intensity. Errors are SEM (n ¼ 3). *** indicates difference from A
Yc-AGPAT2 and AGPAT2-Yc expression, showing calnexin as a loading control.
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protein [28]. Overall, this result indicates that the evolutionarily
conserved luminal loop of seipin and the ﬁrst transmembrane region
may be important for its interaction with AGPAT2.
To investigate the interaction between seipin and AGPAT2 in intact
cells, we employed bimolecular ﬂuorescence complementation (BiFC)
analysis. The C-terminal portion of YFP (Yc) was fused to either the N or
C terminus of AGPAT2 to generate Yc-AGPAT2 or AGPAT2-Yc,
respectively. Similarly, the N-terminal portion of YFP (Yn) was fused to
the N or C terminus of seipin to generate Yn-seipin and seipin-Yn,
respectively. Consistent with an association between AGPAT2 and
seipin, we observed YFP ﬂuorescence when AGPAT2-Yc and seipin-Yn
were co-expressed (Figure 1D,E). However, no YFP ﬂuorescence was
observed with other combinations of seipin and AGPAT2 fusions,
despite equivalent expression of AGPAT2 (Figure 1F). This result ar-
gues strongly against a non-speciﬁc aggregation of these proteins,
which would not be sensitive to the position of the half-YFP proteins in
the fusions.cted with AGPAT2-Myc in the presence or absence of either the short (sht) or long (lg)
ated by SDS-PAGE and immunoblotted with antibodies to FLAG and Myc. Lysates were
AT2 in the absence or presence of either wild-type Myc-seipin (WT) or mutants lacking
second transmembrane domain (DTM2), or the C terminus (DCT). Lysates or anti-FLAG
the interaction of mutant vs wild-type seipin from replicate experiments shown in (B).
-immunoprecipitation with wild-type seipin. (D) HEK293 cells were co-transfected with
the C terminus (S-Yn) of seipin and constructs in which the C-terminal fragment of YFP
ng a temperature shift to induce the formation of reconstituted YFP, cells were ﬁxed and
n and AGPAT2 is indicated by the presence of a YFP signal (yellow). Scale bars, 10 mm.
-Yc/S-Yn (p < 0.001). (F) Representative immunoblot using anti-Myc antibody to detect
n open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 201
Figure 2: Seipin can interact with AGPAT2 in differentiating adipocytes and potentiate adipogenesis. (A) 3T3-L1 preadipocytes were induced to differentiate and immediately co-
transfected with FLAG-seipin-Yn and Myc-AGPAT2-Yc. Cells were ﬁxed after three days of differentiation, and anti-FLAG or anti-Myc antibodies in combination with Alexa Fluor 594
secondary antibodies were used to immunodetect FLAG-seipin-Yn or Myc-AGPAT2-Yc, respectively, as indicated. Identically transfected cells were used to co-immunostain for
FLAG-seipin-Yn and Myc-AGPAT2-Yc (lower panels). Note that these cells were not temperature shifted, preventing the formation of YFP which would otherwise confound the Alexa
Fluor488 ﬂuorescence of the secondary antibody used to detect the FLAG epitope. Scale bars, 10 mm. (B) 3T3-L1 preadipocytes were induced to differentiate and immediately co-
transfected with FLAG-seipin-Yn and Myc-AGPAT2-Yc, as in (A). Following a temperature shift to induce the stable formation of reconstituted YFP, cells were ﬁxed at day 3 of
differentiation and stained for PPARg (red) and DAPI to label nuclei. The direct interaction between seipin and AGPAT2 is indicated by the presence of a YFP signal (yellow). Scale
bars, 10 mm. (C) Quantiﬁed PPARg signal intensity in BiFC-negative (BiFC ve) and BiFC-positive (BiFC þve) cell nuclei. Intensity of PPARg staining was determined in 100 nuclei
each of BiFC-negative and BiFC-positive cells in 3 separate experiments, and mean intensity values were determined for each experiment. Errors are SEM (n ¼ 3). *** indicates
difference from BiFC-positive cell nuclei (p < 0.001). (D) 3T3-L1 preadipocytes were induced to differentiate, immediately co-transfected with FLAG-seipin (with no Yn) and Myc-
AGPAT2-Yc and otherwise treated exactly as those in (B). Cells were ﬁxed at day 3 of differentiation and stained for Myc to identify transfected cells, PPARg and DAPI to label
nuclei. Scale bars, 10 mm. (E) Quantiﬁed PPARg signal intensity in the nuclei of untransfected versus transfected cells. Intensity of PPARg staining was determined in 100 nuclei
each of transfected versus untransfected cells in 3 separate experiments and mean intensity values were determined for each experiment. Errors are SEM (n ¼ 3). ** indicates
difference from untransfected cell nuclei (p < 0.01). (F) Lysates of cells transfected with Myc-AGPAT2-Yc and either FLAG-seipin-Yn or FLAG-seipin as in (B) and (D) were
immunoblotted for AGPAT2 and seipin using anti-Myc and anti-FLAG antibodies, respectively, to determine the relative levels of each protein. Samples were also probed for
calnexin as a loading control.
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Figure 2: (continued ).3.2. Seipin and AGPAT2 can interact during early adipogenesis and
potentiate this process
To investigate the interaction between seipin and AGPAT2 in devel-
oping adipocytes, seipin-Yn and AGPAT2-Yc were co-transfected into
post-conﬂuent 3T3-L1 adipocytes and these cells were induced to
differentiate. A BiFC signal could be clearly detected at the ER of these
cells at day 3 of differentiation, and this signal co-localized signiﬁcantly
with either AGPAT2 or seipin expressed in these cells (Figure 2A). In
similarly transfected cells not subjected to the temperature shift, in
order to prevent the formation of confounding YFP ﬂuorescence, we
observed signiﬁcant co-localization of the seipin-Yn and AGPAT2-Yc
proteins (Figure 2A, lower panels). No reconstitution of BiFC signal
occurred if seipin-Yn was expressed with Yc-AGPAT2 in identically
treated differentiating 3T3-L1 adipocytes, indicating that the associ-
ation of seipin and AGPAT2 in these cells occurs with a speciﬁc
orientation (Figure S1A).
The formation of the reconstituted YFP protein is irreversible and, as
a consequence, the seipin and AGPAT2 to which the half-YFP
proteins are fused will become stably associated. We next deter-
mined whether this stable complex of AGPAT2 and seipin could
inﬂuence adipogenesis. Differentiating 3T3-L1 preadipocytes were
transfected with AGPAT2-Yc and seipin-Yn constructs, and the
nuclear expression of the key pro-adipogenic transcription factor
PPARg was used as a marker of adipogenesis. In preadipocytes
expressing AGPAT2-Yc and seipin-Yn that had been differentiated
for 3 days, the intensity of staining for nuclear PPARg was
signiﬁcantly higher in cells positive for BiFC signal than in BiFC-
negative cells in the same cultures (Figure 2B,C). This did not
result merely from the overexpression of these proteins, as identi-
cally treated cells co-expressing AGPAT2-Yc and FLAG-seipin (not
bearing Yn) displayed only very modestly increased nuclear PPARg
staining compared with untransfected cells in the same cultures
(Figure 2D,E and S1B). This was despite equivalent expression of
AGPAT2-Yc in both cases, and more robust expression of FLAG-
seipin than FLAG-seipin-Yn (Figure 2F). Overall, this result strongly
implies that stabilizing the complex of AGPAT2 and seipin can
functionally alter the rate of differentiation in intact preadipocytes
during early adipogenesis.MOLECULAR METABOLISM 4 (2015) 199e209  2015 The Authors. Published by Elsevier GmbH. This is a
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seipin dodecamers
We next turned to AFM to investigate the molecular architecture of
seipin/AGPAT2 complexes. Following expression in HEK-derived tsA
201 cells, FLAG-AGPAT2 was immunoisolated (Figure 3A), eluted
and subjected to AFM imaging (Figure 3B). Analysis of the volumes
of AGPAT2 particles revealed a single peak at 73  3 nm3
(n ¼ 100) (Figure 3C), close to the expected volume of 64 nm3
calculated from the molecular mass (see supplementary methods).
When FLAG-AGPAT2 and FLAG-seipin-Myc were co-expressed, both
proteins were detected in anti-Myc immunoprecipitates (Figure 3D).
No AGPAT2 was present in anti-Myc immunoprecipitates when
separately transfected cells were mixed prior to lysis, demon-
strating that the association occurs within intact cells (Figure 3E).
AFM analysis of the co-immunoprecipitated proteins following
elution revealed large particles with smaller, peripherally associated
particles (Figure 3F). Zoomed images of representative complexes
are shown in Figure 3G. The peak molecular volume of the pe-
ripheral particles (72  2 nm3; n ¼ 122; Figure 3H) was almost
identical to that of AGPAT2 alone (Figure 3C). The peak volume of
the core of the complex was 2464  20 nm3 (n ¼ 61; Figure 3I),
almost identical to the volume of 2394 nm3 that we have previ-
ously reported for seipin dodecamers [24]. Interestingly, we
observed a number of multiple decorations of the seipin dodeca-
mers by AGPAT2 (Figure 3G). Speciﬁcally, 12.8% (50/391) of seipin
particles were doubly decorated by AGPAT2, and 1.0% (4/391)
were triply decorated. In contrast, no multiple decorations were
seen when seipin was expressed alone (157 particles). The fre-
quency distribution of angles between pairs of bound AGPAT2
molecules had a peak at 69  4 (n ¼ 50; Figure 3J). This
result implies a preference for the binding of any two AGPAT2
molecules to seipin subunits separated by a single seipin subunit,
given that the toroidal, dodecameric arrangement of seipin oligo-
mers should generate an angle of 30 separation between indi-
vidual subunits [24]. Together, these analyses show that AGPAT2
can associate directly with dodecamers of seipin, whilst the precise
molecular architecture of this interaction indicates a speciﬁc and
highly ordered interaction.n open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 203
Figure 3: AFM analysis of AGPAT2 and its interaction with seipin. (A) FLAG-AGPAT2 was expressed in tsA 201 cells and isolated using anti-FLAG immunoafﬁnity chromatography.
Isolated protein was analyzed by SDS-PAGE followed by either silver staining (left panel) or immunoblotting using an anti-FLAG antibody (right panel). The position of AGPAT2 is
indicated at the left, and molecular mass markers (kDa) are shown at the right. (B) Gallery of zoomed AFM images showing individual isolated AGPAT2 particles. Scale bar, 25 nm;
height scale, 0e1 nm. (C) Frequency distribution of volumes of the AGPAT2 particles. The curve indicates the ﬁtted Gaussian function. The peak of the distribution (SEM) is
indicated. (D) FLAG-seipin-Myc and FLAG-AGPAT2 were co-expressed in tsA 201 cells and proteins were isolated using anti-Myc immunoafﬁnity chromatography. Isolated protein
was analyzed by SDS-PAGE followed by immunoblotting using either anti-Myc (top panel) or anti-FLAG (bottom panel) antibodies. The positions of seipin and AGPAT2 are indicated
at the left, and molecular mass markers (kDa) are shown at the right. The bottom panel shows immunoprecipitated AGPAT2 and AGPAT2 expressed alone. (E) Control experiment in
which two batches of cells separately expressing either FLAG-seipin-Myc or FLAG-AGPAT2 were mixed immediately before solubilization, followed by anti-Myc immunoafﬁnity
chromatography. Samples of both total cell lysate and immunoprecipitate were immunoblotted using either anti-Myc (top panel) or anti-FLAG (bottom panel) antibodies. (F) Low-
magniﬁcation AFM image of isolated proteins. Arrowheads indicate large particles (seipin), each decorated by two smaller particles (AGPAT2). Scale bar, 100 nm; height scale, 0e
2 nm. (G) Gallery of zoomed images showing seipin particles decorated by either one (top panels), two (center panels) or three (bottom panels) AGPAT2 particles. Scale bar, 25 nm;
height scale, 0e2 nm. (H) Frequency distribution of volumes of the smaller (AGPAT2) particles. The curve indicates the ﬁtted Gaussian function. The peak of the distribution (SEM)
is indicated. (I) Frequency distribution of volumes of the larger (seipin) particles. (J) Frequency distribution of angles between pairs of bound AGPAT2 particles.
Original article3.4. Seipin dodecamers can directly bind to lipin 1
We next examined the association of lipin 1 with seipin that we have
reported previously. HA-tagged lipin 1a isolated from transfected tsA
201 cells (Figure 4A) had a peak volume of 246  16 nm3 (n ¼ 100;
Figure 4B,C), close to the expected volume of 227 nm3, and to the
volume previously reported by others on the basis of AFM analysis [29].
FLAG-seipin-Myc and HA-lipin 1a could be co-isolated by anti-Myc
immunoafﬁnity chromatography from co-transfected cells
(Figure 4D), but no association was seen when individually transfected
cells were mixed prior to lysis (Figure 4E). AFM imaging of the isolated
proteins revealed large particles decorated by smaller peripheral
particles (Figure 4F). Whilst single decoration events were the most
common, double decorations were also observed. We found that 9.0%
(50/557) of seipin particles were doubly decorated by lipin 1. Zoomed
images of representative complexes are shown in Figure 4G. The peak
molecular volume of the peripheral particles was 208  7 nm3204 MOLECULAR METABOLISM 4 (2015) 199e209  2015 The Authors. Published by Elsevier(n ¼ 116; Figure 4H), whilst the core particles had a peak volume of
2178  12 nm3 (n ¼ 58; Figure 4I). These sizes indicate that the
complexes consist of seipin dodecamers with associated lipin 1
monomers. The distribution of angles between pairs of bound lipin 1
molecules had a peak at 1143 (n¼ 50; Figure 4J), suggesting that
lipin 1 may preferentially bind to seipin subunits separated by two
subunits in the dodecamers, although other conﬁgurations are clearly
possible. Importantly, this analysis reveals that lipin 1 can bind directly
to seipin dodecamers, and conﬁrms that this interaction is speciﬁc and
organized.
3.5. Individual seipin dodecamers can complex both AGPAT2 and
lipin 1
The signiﬁcantly different molecular volumes of AGPAT2 and lipin 1
allowed us to use AFM to assess whether seipin dodecamers might
simultaneously bind both AGPAT2 and lipin 1. Both seipin-Myc andGmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
www.molecularmetabolism.com
Figure 4: AFM analysis of lipin 1 and its interaction with seipin. (A) HA-lipin 1a was expressed in tsA 201 cells and isolated using anti-HA immunoafﬁnity chromatography. Isolated
protein was analyzed by SDS-PAGE followed by either silver staining (left panel), or immunoblotting using either an anti-lipin 1 antibody (center panel) or an anti-HA antibody (right
panel). The position of lipin 1 is indicated at the left, and molecular mass markers (kDa) are shown at the right. (B) Gallery of zoomed AFM images showing individual isolated lipin
1a particles. Scale bar, 25 nm; height scale, 0e1 nm. (C) Frequency distribution of volumes of the lipin 1a particles. The curve indicates the ﬁtted Gaussian function. The peak of
the distribution (SEM) is indicated. (D) FLAG-seipin-Myc and HA-lipin 1a were co-expressed in tsA 201 cells and proteins were isolated using anti-Myc immunoafﬁnity
chromatography. Isolated protein was analyzed by SDS-PAGE followed by immunoblotting using either anti-FLAG (left panel) or anti-lipin 1 (right panel) antibodies. Molecular mass
markers (kDa) are shown at the right. (E) Control experiment in which two batches of cells separately expressing either FLAG-seipin-Myc or HA-lipin 1a were mixed immediately
before solubilization, followed by anti-Myc immunoafﬁnity chromatography. Samples of both total cell lysate and immunoprecipitate were immunoblotted using either anti-FLAG
(top panel) or anti-lipin 1 (bottom panel) antibodies. (F) Low-magniﬁcation AFM image of isolated proteins. The arrowhead indicates a large particle (seipin) decorated by two
smaller particles (lipin 1a). Scale bar, 100 nm; height scale, 0e2 nm. (G) Gallery of zoomed images showing seipin particles decorated by either one (top panels) or two (bottom
panels) lipin 1 particles. Scale bar, 25 nm; height scale, 0e2 nm. (H) Frequency distribution of volumes of the smaller (lipin 1) particles. The curve indicates the ﬁtted Gaussian
function. The peak of the distribution (SEM) is indicated. (I) Frequency distribution of volumes of the larger (seipin) particles. (J) Frequency distribution of angles between pairs of
bound lipin 1 particles.lipin 1 could be detected in immunoprecipitates of FLAG-AGPAT2
from cells co-transfected with seipin-Myc, FLAG-AGPAT2 and HA-
lipin 1a (Figure 5A, IP1). After elution of bound proteins a sec-
ond, anti-Myc immunoprecipitation was performed to enrich for
seipin-Myc-associated AGPAT2. Both FLAG-AGPAT2 and HA-lipin 1a
were detected in this second eluate (Figure 5A, IP2), indicating a
three-way interaction between seipin, AGPAT2 and lipin 1. Impor-
tantly, an anti-Myc IP did not precipitate either FLAG-AGPAT2 or HA-
lipin 1a when singly transfected cells were mixed prior to lysis
(Figure 5B). AFM analysis of the sequentially puriﬁed complexes
revealed multiple seipin dodecamers doubly decorated by a large
and a small peripheral particle, consistent with the binding of both
AGPAT2 and lipin 1 (Figure 5C). Zoomed images are shown in
Figure 5D. We found that 10.1% (50/496) of seipin particles were
doubly decorated by AGPAT2 plus lipin 1. Volume analysis of the
peripheral particles revealed two peaks, at 64  2 nm3, consistentMOLECULAR METABOLISM 4 (2015) 199e209  2015 The Authors. Published by Elsevier GmbH. This is a
www.molecularmetabolism.comwith the volume of AGPAT2, and 292  7 nm3, consistent with the
volume of lipin 1 (n ¼ 132; Figure 5E). The core of the complex had
a molecular volume of 2435  29 nm3 (n ¼ 66), consistent with
that of seipin dodecamers (Figure 5F). Together these data provide
strong evidence that both lipin 1 and AGPAT2 can associate with the
same seipin oligomer. The distribution of angles between the seipin-
associated lipin and AGPAT2 particles had a peak at 78  8
(n ¼ 50; Figure 5G), suggesting that there may be some preference
for a selective distribution of these proteins around the seipin
oligomer. Interestingly, this arrangement would imply that AGPAT2
and lipin 1 could not be simultaneously bound by the A212P and
L91P pathogenic mutants of seipin which we have previously shown
do not appropriately form dodecamers and instead typically
assemble into tetramers [24]
To determine whether the presence of seipin can facilitate the inter-
action between AGPAT2 and lipin 1, we co-transfected cells withn open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 205
Figure 5: Seipin forms a triple complex with AGPAT2 and lipin 1. (A) Seipin-Myc, FLAG-AGPAT2 and HA-lipin 1a were co-expressed in tsA 201 cells. A detergent extract of the
cells was subjected to sequential anti-FLAG (IP1) and anti-Myc (IP2) immunoafﬁnity chromatography steps. Isolated protein was analyzed by SDS-PAGE followed by immunoblotting
using either anti-Myc (seipin; top panels), anti-FLAG (AGPAT2; centre panels) or anti-lipin 1 (bottom panels) antibodies. The positions of the three proteins are indicated at the left,
and molecular mass markers (kDa) are shown at the right. (B) Control experiment in which three batches of cells separately expressing either seipin-Myc, FLAG-AGPAT2 or HA-lipin
1a were mixed immediately before solubilization, followed by anti-Myc immunoafﬁnity chromatography. Samples of both total cell lysate and immunoprecipitate were immu-
noblotted using either anti-Myc (top panel), anti-FLAG (centre panel) or anti-lipin 1 (bottom panel) antibodies. The positions of seipin, AGPAT2 and lipin 1 are indicated at the left,
and molecular mass markers (kDa) are shown at the right. (C) Low-magniﬁcation AFM image of proteins isolated using sequential immunoafﬁnity chromatography, as in (A). The
arrowhead indicates a large particle (seipin) decorated by two differently-sized smaller particles (AGPAT2 and lipin 1). Scale bar, 100 nm; height scale, 0e2 nm. (D) Gallery of
zoomed images showing seipin particles decorated by two differently-sized smaller particles. Scale bar, 25 nm; height scale, 0e2 nm. (E) Frequency distribution of volumes of the
smaller particles (AGPAT2 and lipin 1). The curve indicates the ﬁtted Gaussian functions. The peaks of the distribution (SEM) are indicated. (F) Frequency distribution of the larger
(seipin) particles. (G) Frequency distribution of angles between pairs of bound smaller particles. (H) tsA 201 cells were co-transfected with FLAG-AGPAT2 and HA-lipin 1a in the
absence or presence of wild-type seipin (WT) or seipin lacking either the cytoplasmic C-terminus (DCT) or the ﬁrst transmembrane domain (DTM1). FLAG-AGPAT2 was
immunoprecipitated and lysates or immunoprecipitates (IP) were immunoblotted to determine the levels of FLAG-AGPAT2 and associated Myc-seipin or lipin 1a using anti-FLAG,
anti-Myc and anti-lipin 1 antibodies, as indicated. (I) The levels of lipin 1a associated with immunoprecipitated AGPAT2 in the absence or presence of wild-type or mutant seipin
proteins were determined in three independent experiments. Data shown are means  SEM of co-precipitated lipin 1a normalized to levels of co-precipitated AGPAT2. ** indicates
difference from levels of lipin 1 associated with AGPAT2 in the presence of WT seipin (p < 0.01).
Original articleFLAG-AGPAT2 and lipin 1a in the presence or absence of wild-type
and mutant forms of seipin. Almost no lipin 1 could be detected in
anti-FLAG immunoprecipitates from cells transfected with only FLAG-
AGPAT2 and lipin 1a (Figure 5H). However, co-transfection of wild-
type seipin signiﬁcantly increased the quantity of lipin 1a that could206 MOLECULAR METABOLISM 4 (2015) 199e209  2015 The Authors. Published by Elsevierbe co-immunoprecipitated with AGPAT2. In contrast, co-transfection of
the DTM1 or DCT forms of seipin, which are unable to interact with
AGPAT2 (see Figure 1B,C) or lipin 1 [23], respectively, did not increase
the association between AGPAT2 and lipin 1. Quantiﬁed data are
shown in Figure 5I.GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
www.molecularmetabolism.com
4. DISCUSSION
This is the ﬁrst study to report an association between AGPAT2 and
seipin, two proteins whose disruption accounts for the majority of
cases of CGL [2,3]. As such, it provides the ﬁrst direct link between the
two forms of severe lipodystrophy caused by mutation of the genes
encoding these proteins, and strongly suggests that a common mo-
lecular mechanism may underlie several aspects of the development of
CGL in these cases.
Using AFM imaging, we have shown that the interaction between
AGPAT2 and seipin is direct, as is the association of seipin with lipin 1
that we have described previously. This is important because, alter-
natively, lipin 1 could have been held at the ER by association with its
substrate PA [30,31] or by the CTDNEP1/NEP1-R1 complex, which is
orthologous to the yeast Nem1p/Spo7p complex [32e34]. These two
mechanisms can increase the membrane association of lipin in other
cell types and, in theory, either of these interactions might have been
indirectly inﬂuenced by seipin. However, our data compellingly
demonstrate that a direct interaction can occur making this the most
likely means by which seipin inﬂuences the quantity of lipin 1 asso-
ciated with the ER in developing adipocytes. Interestingly, Creutz et al.
have recently examined the molecular architecture of lipin 1 using AFM
[29]. Consistent with our data, they reported that isolated lipin 1 exists
as monomers under the conditions used here. However, when applied
to a lipid bilayer, they observed that lipin can subsequently self-
assemble into larger oligomers over time. It will be interesting to
determine whether the addition of seipin alters the self-assembly of
lipin complexes in bilayers and whether multiple seipin/lipin 1 com-
plexes might associate under these conditions. Indeed, although our
data demonstrate that seipin can form discrete complexes with lipin
and AGPAT2, it remains possible that seipin could also act in concert
with other scaffold proteins in larger complexes or raft structures in
intact cells.
Our data strongly support a model in which seipin acts as a molecular
scaffold that can associate with both AGPAT2 and lipin simultaneously.
As we previously observed with seipin and lipin 1, only one orientation
of seipin and AGPAT2 BiFC fusion proteins yielded reconstituted YFP
ﬂuorescence. In addition, deletion of the luminal loop domain of seipin
dramatically reduced its interaction with AGPAT2, despite the fact that
this mutant form of seipin is exclusively localized in the ER and
appropriately orientated in the ER membrane as is the wild-type protein
[23,28]. However, the selective geometry of the complexes observed
by AFM provides even greater and very persuasive evidence that the
interaction of either AGPAT2 or lipin with seipin represent speciﬁc and
highly organized associations. This is particularly important in the case
of AGPAT2 and seipin, as both proteins are inserted in the ER mem-
brane, theoretically raising the potential for non-speciﬁc co-
immunoprecipitation.
The triple interaction of both AGPAT2 and lipin 1 with an individual
dodecamer of seipin is particularly interesting, and may facilitate more
efﬁcient supply of PA to associated lipin 1. In our previous study, we
demonstrated that the loss of seipin increased PA levels in developing
adipocytes at an early stage of adipogenesis, when AGPAT2, lipin and
seipin are all critically required for this process [23]. This is consistent
with our model as, in the absence of seipin, PA produced by AGPAT2
would not be efﬁciently supplied to lipin 1 and so would accumulate.
Also consistent with this model, increased PA levels have been re-
ported in other studies of seipin disruption, most recently in the fat of
adipose-speciﬁc seipin null mice [12,15,35]. We focused in this study
on lipin 1, which is critical for adipogenesis in murine cells, but we
demonstrated previously that seipin can bind both lipin 1 and lipin 3MOLECULAR METABOLISM 4 (2015) 199e209  2015 The Authors. Published by Elsevier GmbH. This is a
www.molecularmetabolism.com[23]. It now appears likely that both of these lipin isoforms may in-
ﬂuence adipogenesis [36], perhaps explaining why loss of lipin 1 alone
does not cause overt lipodystrophy in humans [37]. Hence, it may be
relevant that our previous work implies that seipin would be similarly
capable of complexing either lipin 1 or lipin 3 with AGPAT2. Despite
their critical importance, lipin 1 and AGPAT2 are weakly expressed
during the early stages of adipogenesis and become abundant only as
adipocytes mature [6,38,39]. Hence, seipin may be required to in-
crease the localized concentration of AGPAT2 and lipin 1 in domains of
the ER membrane given the relatively low abundance of these en-
zymes. This could facilitate their sequential actions on LPA and PA to
generate adipogenic lipid signals during this initial period of adipocyte
differentiation. We are currently undertaking detailed lipidomic ana-
lyses to deﬁne the consequences of seipin loss on lipids in developing
adipocytes in order to investigate this possibility further.
Whilst our data show that seipin, AGPAT2 and lipin can interact in a
single complex and do so speciﬁcally, we acknowledge that it is a
feature of AFM that the proteins being examined must be overex-
pressed. The lack of suitable antibodies to detect murine seipin and
AGPAT2 in immunoblots has also limited our ability to examine the
interaction of endogenous proteins. As seipin, lipin 1 and AGPAT2 are
poorly expressed during early adipogenesis, it may be technically
challenging to examine their interactions using the techniques
employed here even using reliable antibodies. Nevertheless it is clearly
a priority to apply novel techniques, such as tagging the endogenous
proteins by knock-in, in combination with ﬂuorescent or enzymatic
reporter assays to conﬁrm that the interactions reported here also
occur between endogenous proteins in developing adipocytes. Simi-
larly it will be challenging but important to examine whether these
interactions occur and are important for adipogenesis in vivo. Although
difﬁcult, the recent advances in identifying preadipocyte precursor cell
populations and genetic models to speciﬁcally target these will aid
future attempts to do this [40e43].
Our data provide the ﬁrst evidence that seipin may act as a docking site
for multiple proteins. Given its dodecameric arrangement, it could also
juxtapose alternative proteins in other processes occurring at the ER
membrane. The majority of the metabolic features of congenital seipin
disruption, such as hepatic steatosis and insulin resistance, can be
primarily attributed to the loss of adipose tissue. However, this does
not exclude the potential for important seipin-dependent functions in
other tissues, such as the brain where seipin is highly expressed with a
deﬁned neuroanatomical distribution [44]. Indeed, seipin loss has been
reported to cause anxiety related phenotypes and defective sper-
matogenesis [45,46], whilst other phenotypes could be masked by the
profound metabolic consequences of congenital seipin deﬁciency.
These could result from the loss of seipin’s interaction with proteins
reported here and elsewhere or by additional, as yet undiscovered,
binding partners. Seipin deﬁciency also causes a paradoxical increase
in TG accumulation in a variety of non-adipogenic cells in multiple
species [11e18] as well as in mature adipocytes in vivo [35]. This
phenomenon is difﬁcult to reconcile with the profound ability of seipin
loss to inhibit adipogenesis, and thereby TG accumulation, in devel-
oping adipocytes, and with our observations that seipin may positively
inﬂuence lipin activity [5,7,23]. The ability of seipin loss to increase TG
accumulation may result from interactions with other proteins that
control TG synthesis or hydrolysis. Alternatively, AGPAT2 and lipin 1
may selectively regulate the production of pro-adipogenic signalling
lipids, but not TG, whilst bound to seipin at the ER. Lipogenic enzymes
have been shown to translocate from the ER to the lipid droplet to
promote TG synthesis [47]. Therefore, the loss of seipin could liberate
AGPAT2 and lipin 1 from the ER to take part in TG synthesis at the lipidn open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 207
Original articledroplet. As such this could both inhibit the production of pro-
adipogenic signals in differentiating adipocytes and yet increase the
potential for TG synthesis in mature adipocytes and other cells. Indeed
transgenic overexpression of seipin in mature adipocytes in vivo leads
to reduced TG accumulation and decreased adipocyte size, which
would also be consistent with this effect [48]. Clearly further studies
are required to address these possibilities.
A novel interaction between seipin and the ER calcium pump SERCA
has been reported recently, adding to the growing number of seipin
binding proteins that have been identiﬁed [22]. This is particularly
interesting, as BSCL2 patients frequently suffer from cardiomyopathy
not seen with AGPAT2 deﬁciency in BSCL1 patients. It may be that
altered SERCA function in cardiomyocytes, inﬂuenced by seipin but not
AGPAT2, may at least partly underlie this. Other differences also exist
between the phenotype of BSCL1 and BSCL2 patients, notably that the
adipose tissue loss in BSCL2 is typically more severe. This may be due
to the loss of additional signals inﬂuenced by seipin but not AGPAT2,
partial redundancy amongst AGPAT isoforms or the differences in
tissue distribution of the two proteins. Further studies that delineate
the consequences of seipin or AGPAT2 loss during adipogenesis are
likely to shed light on which of these may occur.
It has been shown that both AGPAT2 and lipin 1 are required for the
activation of PPARg during adipogenesis [9,49]. Similarly, loss of
seipin during adipogenesis leads to an inability to sustain PPARg
expression [5,7,18,19], whilst PPARg agonists can partially ameliorate
the phenotype of lipodystrophic seipin null mice [20]. These studies are
all consistent with our hypothesis that the capacity of seipin to co-
regulate AGPAT2 and lipin might contribute to its critical role in
adipocyte formation. Our data demonstrate that increasing the inter-
action between seipin and AGPAT2 can increase the nuclear accu-
mulation of PPARg. This is only a single indicator of adipogenesis and
so the ﬁrst step in delineating how seipin may control adipogenesis.
Nonetheless, our study is the ﬁrst to show that selectively modulating
the interaction of seipin with a binding partner can directly inﬂuence a
key parameter of adipogenesis. Evidently, further more detailed work
is required to determine the importance of the seipin/AGPAT/lipin
complex in adipocyte differentiation and to further deﬁne the molecular
pathways by which these proteins regulate adipogenesis.
5. CONCLUSIONS
Overall, our data provide the ﬁrst demonstration that seipin dodeca-
mers can act as scaffolds for multiple proteins and can simultaneously
bind both AGPAT2 and lipin 1, two critical regulators of adipogenesis.
Moreover our work provides the ﬁrst direct, physical and mechanistic
link between seipin and AGPAT2, the two proteins whose disruption
most commonly causes severe generalized lipodystrophy in humans.
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